News

argenx Announces Positive Topline Phase 3 ADAPT Trial Results (26th May 2020).

The FcRn blocking technology (Abdeg molecules) was developed in our laboratory and translated into the clinic Argenx.

argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced positive topline data from the pivotal ADAPT trial of efgartigimod. ADAPT met its primary endpoint defined as percentage of responders on the Myasthenia Gravis Activities of Daily Living (MG-ADL) score among acetylcholine receptor-antibody positive (AChR-Ab+) generalized myasthenia gravis (gMG) patients. Responders are defined as having at least a two-point improvement on the MG-ADL score for at least four consecutive weeks. Based on these results, argenx plans to submit a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) by the end of 2020. Click here for more information.

argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia (May 2020).

argenx (Euronext & Nasdaq: ARGX) announced positive topline results from its Phase 2 proof-of-concept clinical trial of efgartigimod (ARGX-113) in adult primary immune thrombocytopenia (ITP) patients. Click here for more information.

argenx receives feedback from Japan’s PMDA on Phase 3 clinical trial and regulatory pathway for efgartigimod in generalized myasthenia gravis (May 2020).

argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced it has received feedback from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan on the design of a Phase 3 trial and regulatory pathway towards potential marketing authorization of efgartigimod (ARGX-113) in patients with generalized myasthenia gravis (gMG). Click here for more information.

Southampton cancer immunologists congratulate the winners of two of this year’s Nobel prizes (December 2019).

Scientists at the Centre for Cancer Immunology have played key roles in immunology research recognised by the 2018 Nobel Prize committee. Click here for more information.

Professors Sally Ward and Greg Winter

Southampton cancer immunologists congratulate the winners of two of this year’s Nobel prizes (December 2019).

Scientists at the Centre for Cancer Immunology have played key roles in immunology research recognised by the 2018 Nobel Prize committee. Click here for more information.

New research programme to develop next generation of cancer immunotherapy treatments. February 2019).

Scientists at the Centre for Cancer Immunology have been awarded £2.2million to develop the next generation of targeted therapy used to treat some cancers. Click here for more information.

We won the 1st place in 2016 Single molecule localization microscopy challenge , Lausanne, Switzerland. (AUGUST 28-30, 2016)

Below is a summary of our performance in different categories:
BiPlane data: 1st place overall, 1st in detection, 1st in overall accuracy.
Double Helix data: 2nd place overall, 3rd in detection, 1st in overall accuracy.
Astigmatic: 1st in overall accuracy.

Ramraj Velmurugan wins Best Poster Presentation award at the Texas Regional Immunology Conference! (NOVEMBER 10-11, 2016)

The winning poster was entitled “Using advanced microscopy techniques to image antibody-dependent macrophage-cancer cell interactions”.

David Kim receives a graduate student travel award for the 2015 Quantitative BioImaging Conference in Paris, France! (JANUARY 7-9, 2015)

Raimund co-organizes the 2015 Quantitative Bioimaging Conference in Paris, France!(JANUARY 7-9, 2015)

Moving to Texas A&M University! (AUGUST 5, 2014)

We are moving the lab to Texas A&M University at College Station. Raimund’s new office is located at Emerging Technologies Building (ETB), Room #5012. The new physical location of the lab is:
Room 464
Joe H. Reynolds Medical Sciences Building, 1114 TAMU
College Station, TX 77843-1114
Phone: (979) 862-7612

New software released! (JUNE 30, 2014)

A new version of the FandPLimitTool, along with the MUMDesignTool have been released. The MUMDesignTool release is associated with our recently published paper.

Raimund co-organizes the 2014 Quantitative Bioimaging Conference! (JANUARY 10-11, 2014)

The main focus of this conference is on the quantitative aspects of single molecule microscopy.

Paper featured in University of Texas at Dallas News Center! (MARCH 20, 2013)

Wining the first place! (JANUARY 16, 2013)

Sungyong You and Eungjoo Lee win first place for their Senior Design project on multiparticle tracking!

Raimund co-organizes the 2013 Quantitative Bioimaging Conference! (JANUARY 11-12, 2013)

The main focus of this conference is on the quantitative aspects of single molecule microscopy.

Raimund co-chairs the IEEE International Symposium on Biomedical Imaging (ISBI 2012)!(MAY 2-5, 2012)

Wining the second place! (JANUARY 18, 2012)

Dongyoung Kim and Taiyoon Lee win second place for their Senior Design project on design of multi-focal plane microscopy!

Paper featured in Global Medical Discovery! (AUGUST 2, 2011)

Global Medical Discovery features breaking research judged by GMD’s advisory team to be of key importance in science and medicine. Papers are selected from over 20,000 published each week from most peer reviewed journals.

Andrea Grosso wins the UT Metroplex Days Poster Award! (MARCH 4, 2011)

Sally co-chairs the Gordon Research Conference ‘Antibody Biology and Engineering’! (MARCH 2010)

Jerry Chao receives an Excellence in Education Fellowship! (JULY 1, 2009)

Prashant Prabhat wins Best Dissertation Award for EE! (JUNE 15, 2009)

Sally co-chairs the Keystone Meeting ‘Antibodies as Drugs’! (MARCH 2009)

Anish Abraham receives a travel award for the Biophysical Society Meeting! (FEBRUARY 2009)

Zhou Gan Receives Travel Award for the ASCB Meeting! (SEPTEMBER 15, 2008)

New software released! (MAY 9, 2008)

A new version of MIATool, along with the FandPLimitTool and the EstimationTool, have been released.

Receiving Young Author Best Paper Award from the IEEE Signal Processing Society! (MARCH 5, 2008)

The paper “Zou, Q., Lin, Z., Ober, R. J. (2006) The Cramer Rao lower bound for bilinear systems, IEEE Trans. Sig. Proc., 54, 1666-1680.” has received the 2007 IEEE Signal Processing Young Author Best Paper Award from the IEEE Signal Processing Society.

Sripad Ram receives National Multiple Sclerosis Society Postdoctoral Fellowship!(FEBRUARY 4, 2008)

Sripad Ram receives Best Speaker Award! (MAY 9, 2007)

Sripad Ram received ‘Outstanding Oral Presentation’ award at the Immunology Graduate Program Scientific Retreat, 2007. The title of Sripad’s talk was “Novel Exocytic Pathways of Neonatal Fc Receptor, FcRn, Revealed by Multifocal Plane Microscopy”.